Atavistik Bio Stock

HealthTech

Operator of a biopharmaceutical company intended to focus on the discovery and development of novel therapies for metabolic diseases and cancer. The company's platform maps metabolite protein interactions and analyzes cellular pathways through quantitative biochemical assays, computational modeling, and high-throughput screening workflows, enabling pharmaceutical and biotechnology organizations to identify novel drug targets, generate mechanistically informed therapeutic candidates, and evaluate biological relevance with greater precision.